Federal award (DEFINITIVE CONTRACT, fiscal year 2021)
Recipient: INSTITUTE FOR CLINICAL PHARMACODYNAMICS, INC.
Awarding agency: Department of Health and Human Services / Food and Drug Administration
Funding agency: Department of Health and Human Services / Food and Drug Administration
Period of performance: 2022-09-22 to 2023-09-29
Current total value of award: $291142
Description: A STUDY IN THE "DEVELOPMENT OF MODERNIZED SUSCEPTIBILITY GUIDANCE FOR ORAL SULFAMETHOXAZOLE-TRIMETHOPRIM USING PHARMACOMETRICS APPROACHES"   BAA PMWP #195